Earlier this week, TACD member and researcher for Public Citizen’s Access to Medicines Program Megan Whiteman spoke at the U.S. […]
Testimony Against Trump Administration Investigation into German Medicine Affordability
TACD raises concerns on use of tariff threats to increase medicine prices in Europe
TACD has published a new statement warning that using tariff threats to pressure countries into raising medicine prices in Europe […]
USTR’s pseudomedicine: undermining drug affordability across the world
Earlier this week, TACD responded to the Trump administration’s request for comments regarding (in their words) Germany’s ‘persistent underpayment for […]
TACD sends urgent call to achieve a swift and comprehensive COVID-19 WTO TRIPS Waiver
The Transatlantic Consumer Dialogue (TACD) has today sent a letter to EU Commission President Ursula von der Leyen and U.S. […]